Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors

por Inrig, Jula K, Bryskin, Suzanne K, Patel, Uptal D, Arcasoy, Murat, Szczech, Lynda A
Publicado 2011

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis

por Komers, Radko, Diva, Ulysses, Inrig, Jula K., Loewen, Andrea, Trachtman, Howard, Rote, William E.
Publicado 2020